WallStreetZenWallStreetZen

NASDAQ: REGN
Regeneron Pharmaceuticals Inc Stock Ownership - Who owns Regeneron Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Regeneron Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Arthur F. RyanDirector2023-02-014$759.65
$3.04kSell
Arthur F. RyanDirector2023-02-012$757.29
$1.51kSell
Arthur F. RyanDirector2023-02-0124$756.77
$18.16kSell
Arthur F. RyanDirector2023-02-0117$755.50
$12.84kSell
Arthur F. RyanDirector2023-02-012$752.11
$1.50kSell
Arthur F. RyanDirector2023-02-013$761.58
$2.28kSell
Arthur F. RyanDirector2023-02-014$760.40
$3.04kSell
Arthur F. RyanDirector2023-02-017$758.58
$5.31kSell
Arthur F. RyanDirector2023-02-012$762.17
$1.52kSell
Marion McCourtEVP Commercial2023-02-011,100$752.19
$827.41kSell

1 of 51

REGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REGN insiders and whales buy or sell their stock.

REGN Shareholders

What type of owners hold Regeneron Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Sanofi33.53%36,518,618$28.60BInsider
Fmr LLC9.93%10,809,746$8.47BInstitution
Blackrock Inc8.71%9,487,243$7.43BInstitution
Vanguard Group Inc7.94%8,648,125$6.77BInstitution
Capital World Investors5.72%6,225,599$4.88BInstitution
Jpmorgan Chase Co5.24%5,705,869$4.47BInstitution
State Street Corp4.64%5,051,759$3.96BInstitution
Wellington Management Group LLP2.24%2,443,289$1.91BInstitution
Dodge Cox2.10%2,286,509$1.79BInstitution
Geode Capital Management LLC2.06%2,240,113$1.75BInstitution

1 of 3

REGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REGN69.51%30.49%Net SellingNet Selling
VRTX90.97%1.60%Net SellingNet Selling
MRNA63.11%22.45%Net SellingNet Selling
BNTX15.26%0.00%
ALNY82.68%17.32%Net SellingNet Selling
View Top Biotech Stocks

Regeneron Pharmaceuticals Stock Ownership FAQ

Who owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals (NASDAQ: REGN) is owned by 84.26% institutional shareholders, 36.96% Regeneron Pharmaceuticals insiders, and 0.00% retail investors. Sanofi is the largest individual Regeneron Pharmaceuticals shareholder, owning 36.52M shares representing 33.53% of the company. Sanofi's Regeneron Pharmaceuticals shares are currently valued at $28.60B.

If you're new to stock investing, here's how to buy Regeneron Pharmaceuticals stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.